logo
Torture or treatment? The rise of Nottingham's pioneering asylum

Torture or treatment? The rise of Nottingham's pioneering asylum

BBC News26-05-2025
"One can hardly imagine a human being in a more degraded and brutalised condition than that in which I found this female."These were the damning words of an inspector who visited London's Bethlem Royal Hospital in 1814 - better known by its notorious nickname, Bedlam.And while such harrowing scenes had long been the norm, a quiet revolution in mental healthcare was already under way. It started not in the capital, but in Nottingham.Now, new publishings into the groundbreaking Nottingham General Lunatic Asylum - the first publicly-funded asylum in England - has shone light into some of medical history's darkest corners.
When the institution opened in 1812, the asylum had already doubled its projected cost, with the final bill reaching £20,000 - an eye-watering sum for the era.
Author and researcher David Whitfield has drawn on his extensive study of the institution for his latest novel, The Unravelling of Mary Reddish, which brings to life the true story of a former patient.He said: "It is very easy to look back and be shocked and appalled by the things that went on."But when you look at letters and speeches of the people who set Nottingham up, you get a different perspective."It is unlikely to come as a surprise that the treatment of the mentally ill in earlier centuries was grim - but just how grim takes some believing.Forced vomiting and diarrhoea, bleeding, blistering with hot irons, spinning and cold water immersion were all recommended - in addition to simply being chained to a wall for weeks on end.
Victoria Sweetmore, head of mental health and learning disability nursing at the University of Derby, is also studying for a PhD on the history of nursing at the University of Nottingham."What you had is people living in private mad houses, private institutions," she said. "There was absolutely no kind of oversight of these places, they were just run by anybody who fancied running one."There were no standards. There was just nothing. So people were kept in appalling conditions, you know, kind of chained up left with rags, fed scraps. "On top of that they were treated like zoos, with people paying to come and see the inmates."For a time in the 18th Century, Bedlam was the second most popular attraction in London and measures had to be taken to deal with visitor overcrowding during the Christmas and Easter holidays.This in turn attracted thieves, pedlars and prostitutes, but also a level of critical scrutiny.
Ms Sweetmore said: "It was increasingly felt that this wasn't acceptable. "So there was this real push towards making sure that as a society we were looking after people, particularly what they term the pauper lunatics who were either being held in workhouses, in prisons, at home or often just forced to wander the streets."The issue was also twice highlighted by King George III who in 1788 suffered a mental breakdown, and then in 1800 survived an assassination attempt by a man who was saved from the noose by a new and much wider application of the insanity plea.This led to the County Asylums Act 1808, which allowed local authorities to raise public funds for the care of mentally ill people in regulated institutions.After years of fitful private fundraising, this spurred community leaders in Nottingham to open the Nottingham General Lunatic Asylum.Sited in extensive gardens in the fields of Sneinton, shielded from public gaze and away from the noise of the city, it was the first of its kind in the country.
Mr Whitfield said a new ethos of "moral treatment" did not mean a move to modern standards.He said: "Looking back, it seems very dark to us because of the kind of treatments that were used back then."There was the chair, the purges, the emetics, all these things that were designed to try and essentially drag bad things out of people, which is how it was seen."Having said that, at the time, it was set up to be quite humane."The rooms were clean, the patients had privacy, restraints were kept to a minimum and staff were instructed to display "tenderness and gentleness"." Possible insights into the limits of the therapies available at Nottingham comes from the 1814 accounts which show that of the £1427 annual spend, £137 went on beer and ale, £9 9s on wine and just £7 6s on medicines.
Mr Whitfield turned some of findings into his novel, focusing on a real life patient, Mary Reddish.When admitted in 1827 her first medical record stated "her moral conduct has not been correct"."That's the only clue as to what she really had," he said."Her notes go on to say "violent, incoherent, impetuous" and she is described as a "violent lunatic" – but in terms of diagnosis in terms of what we would know it, that is completely absent."But when you look at it in a broader sense, in particular why women were in there, they seem to be things we think of as common today."Things that sound like post natal depression, menopause - or a "change in constitution" as it was described - and "disappointed affection" which could simply be a bad break up."
Mary was subjected to the chair, which spun the patient around until they passed out.Remarkably, it was reported that "good effects are ascribed to the chair and she continues to improve in mind and body".Mr Whitfield said: "Who knows what this really means? I've had to take a view of this in the book but you can only go on what the doctor has chosen to write down at the time."While 'treatments' like spinning and blistering were phased out, Nottingham's asylum soon came to face a challenge common with modern healthcare - overcrowding.Originally built to house 80 people, by the end of 1857 it held 247 - 130 men and 117 women.Of these 31 were deemed potentially curable.
The fate of the incurable can also be glimpsed the same year, when the last remaining private patient, a woman, died after almost 39 years in the asylum.The decades took their toll on the institution, and with patient numbers still climbing, new asylums had to be built further out.By 1891, with buildings aging and the expanding city crowding around, commissioners described the original asylum as "inconvenient, ill constructed [and] ill adapted".It closed in 1902, with most of the buildings knocked down soon after - though the site, now a public park, was not fully cleared until the 1960s.The only reminder is a plaque on the final surviving fragment, a red brick pillar which formed part of an entrance gate.Ms Sweetmore added: "Asylums were largely closed down in the late 20th Century but places like Nottingham, for all their failings, were a big step away from what went before."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Huge breast cancer breakthrough as scientists discover key way to prevent deadly disease
Huge breast cancer breakthrough as scientists discover key way to prevent deadly disease

Daily Mail​

time10 minutes ago

  • Daily Mail​

Huge breast cancer breakthrough as scientists discover key way to prevent deadly disease

Scientists have discovered how breast cancer spreads to other parts of the body—and it could revolutionise how the disease is treated in its earlier stages. Scottish researchers discovered that cancer changes the metabolism—the way cells make and use energy—of specific immune cells. They found that they release a certain sort of protein, called uracil, which can be used as a 'scaffold' by cancerous cells, allowing them to grow on other organs. Scientists were able to block the uracil-powered scaffold from forming in mice. This restored the ability of the creatures' immune systems to kill secondary cancer cells, and stop the cancer from spreading. The scientists achieved this by blocking an enzyme called uridine phosphorylase-1 (UPP1), which produces uracil. They hope that detecting uracil in the blood may help spot early signs the cancer spreading—and blocking UPP1 with drugs could stop the spread before it even starts. The findings of the study, which was carried out in the labs of Professor Jim Norman and Professor Karen Blyth, were published in the Embo Reports journal. Lead author of the study, Dr Cassie Clarke, said: 'This study represents a major shift in how we think about preventing the spread of cancer. 'By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives.' Meanwhile, Dr Catherine Elliot, director of research at Cancer Research UK, said: 'Metastasis—when cancer spreads—is a major factor in breast cancer becoming harder to treat, especially if the cancer returns months or even many years later. 'This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones.' The research may also help stop the spread of other cancers to other parts of the body, too added Simon Vincent, chief scientific officer at Breast Cancer Now. 'Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers,' he said. The team of researchers at from the Cancer Research UK Institute and University of Glasgow are now testing the ability of drugs to prevent cancer occurring. It comes amid an alarming prediction earlier this year that breast cancer deaths in the UK will soar by more than 40 per cent by 2050. By the same year, globally, another study estimated there will be 3.2million new cases and 1.1million breast-related deaths per year if current trends continue. The disease is far more prevalent in those over 50, which is the age women typically experience the menopause. It is the most common type of cancer in the UK, taking the lives of around 11,500 Britons and 42,000 Americans each year. Early signs of the disease are a lump in the breast, swelling or lump in the armpit, change in size or shape of breasts, discharge of fluid from the nipple. Others include dimpling, a rash or redness on skin, as well as crusting, scaly or itchy skin on the nipple. Despite years of pleas from cancer charities, more than a third of women in the UK still do not regularly assess their breasts. However, it should be part of your monthly routine, so you can notice any unusual changes, charity CoppaFeel previously said. You can check in the shower, when you are lying down in bed or in the mirror before you get dressed. Because breast tissue isn't just found in your boobs, it's also important that men and women check the tissue all the way to their collarbone and underneath their armpit. There is no right or wrong way to check your breasts, as long as you know how your breasts usually look and feel, says the NHS. Breast cancer is one of the most common cancers in the world and affects more than two MILLION women a year Breast cancer is one of the most common cancers in the world. Each year in the UK there are more than 55,000 new cases, and the disease claims the lives of 11,500 women. In the US, it strikes 266,000 each year and kills 40,000. But what causes it and how can it be treated? What is breast cancer? It comes from a cancerous cell which develops in the lining of a duct or lobule in one of the breasts. When the breast cancer has spread into surrounding tissue it is called 'invasive'. Some people are diagnosed with 'carcinoma in situ', where no cancer cells have grown beyond the duct or lobule. Most cases develop in those over the age of 50 but younger women are sometimes affected. Breast cancer can develop in men, though this is rare. Staging indicates how big the cancer is and whether it has spread. Stage 1 is the earliest stage and stage 4 means the cancer has spread to another part of the body. The cancerous cells are graded from low, which means a slow growth, to high, which is fast-growing. High-grade cancers are more likely to come back after they have first been treated. What causes breast cancer? A cancerous tumour starts from one abnormal cell. The exact reason why a cell becomes cancerous is unclear. It is thought that something damages or alters certain genes in the cell. This makes the cell abnormal and multiply 'out of control'. Although breast cancer can develop for no apparent reason, there are some risk factors that can increase the chance, such as genetics. What are the symptoms of breast cancer? The usual first symptom is a painless lump in the breast, although most are not cancerous and are fluid filled cysts, which are benign. The first place that breast cancer usually spreads to is the lymph nodes in the armpit. If this occurs you will develop a swelling or lump in an armpit. How is breast cancer diagnosed? Initial assessment: A doctor examines the breasts and armpits. They may do tests such as a mammography, a special x-ray of the breast tissue which can indicate the possibility of tumours. Biopsy: A biopsy is when a small sample of tissue is removed from a part of the body. The sample is then examined under a microscope to look for abnormal cells. The sample can confirm or rule out cancer. If you are confirmed to have breast cancer, further tests may be needed to assess if it has spread. For example, blood tests, an ultrasound scan of the liver or a chest X-ray. How is breast cancer treated? Treatment options which may be considered include surgery, chemotherapy, radiotherapy and hormone treatment. Often a combination of two or more of these treatments are used. Surgery: Breast-conserving surgery or the removal of the affected breast depending on the size of the tumour. Radiotherapy: A treatment which uses high energy beams of radiation focused on cancerous tissue. This kills cancer cells, or stops them from multiplying. It is mainly used in addition to surgery. Chemotherapy: A treatment of cancer by using anti-cancer drugs which kill cancer cells, or stop them from multiplying. Hormone treatments: Some types of breast cancer are affected by the 'female' hormone oestrogen, which can stimulate the cancer cells to divide and multiply. Treatments which reduce the level of these hormones, or prevent them from working, are commonly used in people with breast cancer. How successful is treatment? The outlook is best in those who are diagnosed when the cancer is still small, and has not spread. Surgical removal of a tumour in an early stage may then give a good chance of cure. The routine mammography offered to women between the ages of 50 and 71 means more breast cancers are being diagnosed and treated at an early stage. For more information visit or call its free helpline on 0808 800 6000 But one of the most popular methods online involves using the pads of your fingers. Examining your entire breast and armpit area, simply, rub and feel from top to bottom of the breast. You should also feel in semi-circles and in a circular motion around your breast tissue to feel for any abnormalities, according to a guide shared in a blog post by the University of Nottingham. Then look in the mirror for any visual lumps, skin texture and changes and changes in nipple shape or abnormal discharge. If you spot any changes, you should get it checked out by your GP. Women aged between 50 and 70 should also be attending routine breast cancer screenings.

Date set for 24-hour stroke treatment rollout at Royal Preston
Date set for 24-hour stroke treatment rollout at Royal Preston

BBC News

time10 minutes ago

  • BBC News

Date set for 24-hour stroke treatment rollout at Royal Preston

A potentially life-saving stroke treatment will be available around the clock in Lancashire by early next year, according to the region's health board. The Royal Preston Hospital already offers the procedure, known as a thrombectomy, to suitable patients in Lancashire and South Cumbira – but only between 08:00 and 18:00 BST. The hospital was set to start offering the procedure at all hours of the day by September 2024, but the plan had to be pushed back because of difficulties recruiting staff. A meeting of the NHS Lancashire and South Cumbria Integrated Care Board (ICB) heard that the treatment would be offered 24 hours a day from 1 February 2026 at the latest. A thrombectomy is only utilised to treat strokes caused by a blood clot in a large artery in the brain. The procedure involves surgically removing the clot, but it has to be done soon after a stroke occurs to be Christopher Long recently warned that limited access to the procedure posed a life-threatening risk to patients in Lancashire and South Cumbria, according to the Local Democracy Reporting Service (LDRS). He issued the warning at an inquest earlier this year into the death of Michelle Mason, 45, who died at the Royal Lancaster Infirmary in June 2024 after suffering a treatment was "considered" in her case, but would not have been available at the time she needed it, the coroner heard. The ICB's acting medical director, Dr Andy Knox, told the meeting the hospital had now recruited enough interventional radiologists "to be able to fulfil the rota requirements" of 24-hour he said more time was needed to bring in a new consultant. Dr Knox said the ICB was pushing for the Lancashire Teaching Hospitals NHS Foundation Trust, which runs the Royal Preston Hospital, to roll out the 24-hour programme by October. However, he acknowledged it would place the hospital under additional pressure, adding: "We know that things will be in place by 1st February."He said co-operation had improved with other trusts within north-west England meaning patients from Lancashire and South Cumbria could be transferred elsewhere for a thrombectomy when required in the meantime. The LDRS has approached the trust for comment. Listen to the best of BBC Radio Lancashire on Sounds and follow BBC Lancashire on Facebook, X and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230.

German pharma firm signs deal worth up to $1bn with QUB spin out
German pharma firm signs deal worth up to $1bn with QUB spin out

BBC News

time40 minutes ago

  • BBC News

German pharma firm signs deal worth up to $1bn with QUB spin out

A medical technology company founded by Queen's University academics has signed a licensing agreement with a major pharmaceutical firm which could ultimately be worth up to $1bn (£744.1m).Re-Vana Therapeutics, which was set up in 2016, develops products to improve the delivery of drugs for chronic eye diseases, increasing the quality of care for major benefit of its technology is that it reduces the number of eye injections patients require making them more likely to follow their Ingelheim, a German pharmaceutical firm, is licensing the drug delivery system to combine it with its eye medications. The German firm will take responsibility for regulatory approvals and global commercialization of products developed using the Re-Vana Ingelheim said the deal involves "upfront, development, regulatory and commercial milestone payments to Re-Vana, with total potential deal value exceeding $1bn for the initial three targets, in addition to royalty payments on net sales".Re-Vana was founded by Professor Raj Thakur and Professor David Jones with investors including Qubis, the commercialisation arm of Queen's company is now based in the US but still has its research base in O'Rourke, Re-Vana's Chief Executive Officer, said the collaboration with Boehringer Ingelheim is a "transformational moment".The deal has also been welcomed by NI Secretary of State Hillary Benn who said it "represents a huge vote of confidence in Northern Ireland's innovation and skills".

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store